These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 18691602)

  • 1. Chromatin, cancer and drug therapies.
    Cortez CC; Jones PA
    Mutat Res; 2008 Dec; 647(1-2):44-51. PubMed ID: 18691602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation.
    Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
    Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
    Santini V; Gozzini A; Ferrari G
    Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Modulators as Treatment Alternative to Diverse Types of Cancer.
    Gutiérrez JR; Salgado ARM; Arias MÁ; San-Juan-Vergara H; Rada WR; Gómez CMM
    Curr Med Chem; 2022; 29(9):1503-1542. PubMed ID: 34963430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Therapies and Potential Drugs for Treating Human Cancer.
    Lin SQ; Li X
    Curr Drug Targets; 2020; 21(11):1068-1083. PubMed ID: 32209040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery.
    Ganesan A; Nolan L; Crabb SJ; Packham G
    Curr Cancer Drug Targets; 2009 Dec; 9(8):963-81. PubMed ID: 20025605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of gene expression as an anticancer drug target.
    Ferguson LR; Tatham AL; Lin Z; Denny WA
    Curr Cancer Drug Targets; 2011 Feb; 11(2):199-212. PubMed ID: 21158714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic targets in cancer: the epigenetic connection.
    Herranz M; Esteller M
    Clin Transl Oncol; 2006 Apr; 8(4):242-9. PubMed ID: 16648099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic therapy for solid tumors: from bench science to clinical trials.
    Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
    Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Alcohol-Induced Epigenetic Modifications in the Treatment of Alcohol use Disorders.
    Fanfarillo F; Ferraguti G; Lucarelli M; Fuso A; Ceccanti M; Terracina S; Micangeli G; Tarani L; Fiore M
    Curr Med Chem; 2024; 31(36):5837-5855. PubMed ID: 37828672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
    Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin remodeling, cancer and chemotherapy.
    Dey P
    Curr Med Chem; 2006; 13(24):2909-19. PubMed ID: 17073637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research Progress of Epigenetics in Pathogenesis and Treatment of Malignant Tumors].
    Wang P; Zhao H; Ren F; Zhao Q; Shi R; Liu X; Liu J; Li Y; Li Y; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):91-100. PubMed ID: 32093453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
    Simó-Riudalbas L; Esteller M
    Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy.
    Myasoedova VA; Sukhorukov V; Grechko AV; Zhang D; Romanenko E; Orekhov V; Orekhov AN
    Curr Pharm Des; 2019; 25(6):635-641. PubMed ID: 30950345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.